News results: "Avastin"

« 25 results in "Health"« 1 results in "Science"« 2 results in "Specials"
« 1 results in "Business"« 1 results in "World"
dotclear

Health

Cancer Drug Avastin Meets Endpoint In Late Stage Trial

Cancer Drug Avastin Meets Endpoint In Late Stage Trial

The outcome of the most recent study of Avastin revealed that the cancer drug is indeed effective...
» read full story November 24th, 2008 - 21:12

Avastin Raises Risk of Blood Clots

An analysis of 15 clinical trials involving Genentech’s cancer drug Avastin has found that the...
» read full story November 20th, 2008 - 16:37
Avastin Drug Linked to Blood Clots

Avastin Drug Linked to Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 19th, 2008 - 19:56
Avastin Linked to Blood Clot Risk, New Analysis Finds

Avastin Linked to Blood Clot Risk, New Analysis Finds

Genentech’s cancer drug Avastin was linked to a significantly increased risk of blood clots in the...
» read full story November 19th, 2008 - 14:10
Study: Tarceva Delays Progress Of Lung Cancer

Study: Tarceva Delays Progress Of Lung Cancer

Tarceva’s manufacturers, Genetech Inc and OSI Pharmaceuticals, said the drug proved its...
» read full story November 09th, 2008 - 13:31
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
» read full story November 08th, 2008 - 23:55
Tarceva Slows Progress Of Lung Cancer, Study Shows

Tarceva Slows Progress Of Lung Cancer, Study Shows

After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
» read full story November 08th, 2008 - 14:33
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 08th, 2008 - 14:30
Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Drug maker Genentech Inc. seeks regulatory approval for its cancer drug Avastin in patients with...
» read full story November 04th, 2008 - 15:40

Genentech’s Avastin reaches Phase 3

Genentech has recently announced that the study of Avastin will continue as planned, reaching phase...
» read full story October 20th, 2008 - 22:42
Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Genentech Inc. and Biogen Idec Inc. announced that their drug Rituxan combined with chemotherapy...
» read full story October 08th, 2008 - 14:40
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

According to the results of a late-stage clinical trial into the benefits of combining Genentech’s...
» read full story October 07th, 2008 - 14:00
Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
» read full story October 06th, 2008 - 22:31
Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s cancer drug Avastin is now facing a halt in approval for expanded use because of its...
» read full story July 07th, 2008 - 15:51
New Data Triggers Revision of Erbitrux vs. Avastin Study

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...
» read full story June 04th, 2008 - 22:37
Erbitux Boosts Survival in Lung Cancer Patients

Erbitux Boosts Survival in Lung Cancer Patients

Results of a long awaited clinical trial of ImClone Systems Inc's Erbitux, called Flex, give hopes...
» read full story June 01st, 2008 - 08:50
EU Backs Merck KGaA’s Erbitux for First-Line Use

EU Backs Merck KGaA’s Erbitux for First-Line Use

Germany’s Merck KGaA announced Friday that Erbitux, which it licensed from ImClone System Inc and...
» read full story May 31st, 2008 - 08:20
Avastin’s Approval Leads to Jump in Shares for Roche

Avastin’s Approval Leads to Jump in Shares for Roche

The forecasts for Roche Holding AG saw quite a spike on Monday following the announcement that the...
» read full story February 25th, 2008 - 14:39
Avastin Approved for Breast Cancer

Avastin Approved for Breast Cancer

The Food and Drug Administration announced in December that Genentech Inc.'s drug Avastin failed to...
» read full story February 22nd, 2008 - 23:21
Avastin Found To Be Effective In Breast Cancer Treatment

Avastin Found To Be Effective In Breast Cancer Treatment

The latest clinical trials have shown that Genentech’s cancer drug, Avastin, proved its...
» read full story February 13th, 2008 - 15:32
Judah Folkman, Pioneer of Angiogenesis Research Dies at 74

Judah Folkman, Pioneer of Angiogenesis Research Dies at 74

Scientific world lost one of its notorious personalities on Monday, as Dr. Judah Folkman,...
» read full story January 16th, 2008 - 11:27
Avastin: Too Risky In Case Of Breast Cancer

Avastin: Too Risky In Case Of Breast Cancer

This Thursday a government panel ruled that Avastin is too risky in case of breast cancer...
» read full story December 06th, 2007 - 21:57
FDA Questions Benefits of Avastin for Breast Cancer

FDA Questions Benefits of Avastin for Breast Cancer

The Food and Drug Administration announced that Genentech Inc.'s drug Avastin failed to help breast...
» read full story December 03rd, 2007 - 21:17
Genentech’s Avastin Promising for Brain Cancer Treatment

Genentech’s Avastin Promising for Brain Cancer Treatment

U.S. biotechnology company Genentech Inc. revealed on Sunday that its cancer drug, Avastin, seems...
» read full story November 21st, 2007 - 15:03
Roche's Genentech Announces Avastin Works for GBM

Roche's Genentech Announces Avastin Works for GBM

Genentech Inc announced its Avastin (active ingredient: bevacizumab), a monoclonal antibody against...
» read full story November 18th, 2007 - 23:24
dotclear

Science

Avastin Drug Linked To Blood Clots

Avastin Drug Linked To Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 20th, 2008 - 11:00
dotclear

Specials

Study: Cancer Drug Avastin Increases Blood Cloths Risk

Study: Cancer Drug Avastin Increases Blood Cloths Risk

Avastin, Genentech’s best-selling drug, increases the risk of people developing blood clots,...
» read full story November 19th, 2008 - 16:48
Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Lung cancer drug Tarceva jointly developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche...
» read full story November 10th, 2008 - 15:08
dotclear

Business

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 10th, 2008 - 06:58
dotclear

World

EU Backs Erbitux as First Line Drug Against Cancer

EU Backs Erbitux as First Line Drug Against Cancer

The European Medicines Agency, based in London, has approved the use of Erbitux, produced by Merck...
» read full story June 02nd, 2008 - 11:07
dotclear
dotclear
dotclear
Photos Gallery
dotclear